Job/Unit: O20691
/KAP1
Date: 13-08-12 16:33:40
Pages: 11
Lyngbyabellins K–N from the Marine Cyanobacterium Moorea bouillonii
served by ESIMS, and the 1H NMR chemical shift was assigned
synthesized from l- (1 g) and d-leucine (1 g), respectively, according
to a procedure reported by Reetz et al. to yield the benzyl-protected
aldehyde.[20] An aliquot (3.38 mmol) of the benzyl-protected alde-
hydes dissolved in tetrahydrofuran (15 mL) was then added to a
solution of tert-butyl acetate (3.72 mmol) and freshly prepared lith-
ium diisoproplyamine (5.06 mmol). The reaction mixture was
warmed to –40 °C for 1 h and then quenched with NaHCO3
(85 mL), filtered, and the aqueous layer was separated and washed
with Et2O (2ϫ 20 mL). The organic layer was then washed with
brine and dried with NaSO4 and filtered to yield diastereomeric
tert-butyl 4-(dibenzylamino)-3-hydroxy-6-methylheptanoate. The
mixture of diastereomers were inseparable; thus, the method out-
lined by Andrés et al. was used, where the benzyl-protected amine
was converted into the Boc-protected derivative allowing for purifi-
cation of a small amount of each of the diastereomers.[21] Each of
the diastereomers were identified by a comparison of 1H NMR
spectra of each of the pure standards to the known compounds
reported in the literature.[21] An aliquot (2 mg) of each protected
statine was treated with 6 n HCl (1 mL) and heated to 160 °C in a
microwave reactor for 5 min. Each of the hydrolysate products was
dried with N2 (g) and then treated with Marfey’s reagent as men-
tioned above to yield the four Marfey-derived statine standards.
by COSY.
3,14-Di-(S)-MTPA Ester of Lyngbyabellin M (6): Pale yellow
amorphous solid. 1H NMR (CDCl3, 600 MHz): δ = 8.16 (s, 1 H,
12-H), 7.96 (s, 1 H, 13-H), 6.78 (dd, J = 7.6, 2.9 Hz, 1 H, 14-H),
5.98 (d, J = 5.4 Hz, 1 H, 20-H), 5.48 (td, J = 7.6, 3.4 Hz, 1 H, 3-
H), 5.07 (dd, J = 12.3, 2.9 Hz, 1 H, 15-Ha), 4.79 (dd, J = 12.3,
7.6 Hz, 1 H, 15-Hb), 4.43 (q, J = 7.1 Hz, 2 H, 24-H2), 3.05 (dq, J
= 7.6, 7.2 Hz, 1 H, 2-H), 2.41 (m, 1 H, 21-H), 2.12 (m, 1 H, 6-Ha),
2.07 (m, 1 H, 6-Hb), 2.06 (s, 3 H, 8-H3), 1.73 (m, 1 H, 5-Ha), 1.68
(m, 1 H, 5-Hb), 1.59 (m, 2 H, 4-H2), 1.41 (t, J = 7.1 Hz, 3 H, 25-
H3), 1.28 (d, J = 7.2 Hz, 3 H, 9-H3), 0.96 (d, J = 6.8 Hz, 3 H, 22-
H3), 0.95 (d, J = 6.8 Hz, 3 H, 23-H3) ppm. LR ESIMS: m/z =
1057.02 [M + H]+, 1079.12 [M + Na]+.
3,14-Di-(R)-MTPA Ester of Lyngbyabellin M (7): Pale yellow
amorphous solid. 1H NMR (CDCl3, 600 MHz): δ = 8.22 (s, 1 H,
12-H), 7.88 (s, 1 H, 18-H), 6.72 (dd, J = 7.1, 3.1 Hz, 1 H, 14-H),
5.95 (d, J = 5.4 Hz, 1 H, 20-H), 5.47 (m, 1 H, 3-H), 4.98 (dd, J =
12.3, 3.1 Hz, 1 H, 15-Ha), 4.78 (dd, J = 12.3, 7.1 Hz, 1 H, 15-Hb),
4.44 (q, J = 7.1 Hz, 2 H, 24-H2), 3.05 (m, 1 H, 2-H), 2.42 (m, 1 H,
21-H), 2.19 (m, 1 H, 6-Ha), 2.14 (m, 1 H, 6-Hb), 2.11 (s, 3 H, 8-
H3), 1.78 (m, 1 H, 5-Ha), 1.68 (m, 1 H, 5-Hb), 1.76 (m, 2 H, 4-
H2), 1.42 (t, J = 7.1 Hz, 3 H, 25-H3), 1.16 (d, J = 7.2 Hz, 1 H, 9-
H), 0.95 (d, J = 6.8 Hz, 6 H, 22-H3, 23-H3) ppm. LR ESIMS: m/z
= 1056.99 [M + H]+, 1079.07.58 [M + Na]+.
Preparation and GC–MS Analysis of HIVA: An aliquot (ca. 500 μg)
of the hydrolysate was treated with an excess of CH2N2 at room
temperature for 30 min and dried under N2 (g). Correspondingly,
l- and d-HIVA were synthesized as described above. The products
were dissolved in CH2Cl2 and injected into a chiral GC–MS instru-
ment with a Chiralsil-Val column (Agilent Technologies J&W Sci-
entific, 30 mϫ0.25 mm) under the following conditions: the initial
oven temperature was 32 °C, kept for 15 min, followed by a ramp
from 32 to 60 °C at a rate of 10 °C/min, followed by another ramp
to 200 °C, at a rate of 15 °C/min and kept at 200 °C for 5 min. The
retention time of products resulting from the acid hydrolysate of 4
matched those of the synthetic (2S)-HIVA standard [9.7 min; (2R)-
HIVA, 10.2 min].
Cytotoxicity Assay: H-460 cells were added to 96-well plates at
3.33ϫ104 cells/mL of Roswell Park Memorial Institute (RPMI)
1640 medium with 10% fetal bovine serum (FBS) and 1% penicil-
lin/streptomycin. The cells, in a volume of 180 μL per well, were
incubated overnight (37 °C, 5% CO2) to allow recovery before
treatment with test compounds. Compounds were dissolved in
DMSO to a stock concentration of 10 mg/mL. Working solutions
of the compounds were made in RPMI 1640 medium without FBS,
with a volume of 20 μL added to each well to give a final com-
pound concentration of either 30 or 3 μg/mL. An equal volume of
RPMI 1640 medium without FBS was added to wells designated
as negative controls for each plate. Plates were incubated for ap-
proximately 48 h before being stained with 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT). By using a Thermo-
Electron Multiskan Ascent plate reader, plates were read at 570 and
630 nm. Concentration response graphs were generated by using
GraphPad Prism (GraphPad Software Inc., San Diego, CA).
Preparation and GC–MS Analysis of DiMeVal: The methylated hy-
drolysate product of 5 was analyzed by chiral GC–MS using a Cy-
closil
B
column (Agilent Technologies J&W Scientific,
30 mϫ0.25 mm) under the following conditions: the initial oven
temperature was 34 °C and kept for 68 min, followed by a ramp
from 34 to 100 °C at a rate of 30 °C/min and kept at 100 °C for
5 min. Synthetic standards of (2S)- and (2R)-DiMeVal were first
methylated by dissolving each starting material (10 mg) in H2O
(433 μL), followed by the addition of formaldehyde (27 μL) and
10% Pd/C (10.4 mg). The mixture was then treated with H2 (g) for
16 h. After 16 h, the reaction mixtures were brought to a boil and
then concentrated in vacuo. Each of the synthetic standards were
then treated with CH2N2 for 5 min and then dried with N2 (g),
resuspended in CH2Cl2, then analyzed by chiral GC–MS. The re-
tention time of products resulting from the acid hydrolysate of 5
matched that of the authentic (2S)-DiMeVal standard [63.7 min;
(2R)-DiMeVal, 64.2 min].
Supporting Information (see footnote on the first page of this arti-
1
cle): H NMR, 13C NMR, COSY, gHSQC, and HMBC spectra in
1
CDCl3 for lyngbyabellin K and M (1 and 4). H NMR spectra in
CDCl3 for the Mosher derivatives of lyngbyabellin M (4). 1H
NMR, 13C NMR, gHSQC, COSY, HMBC, DQF-COSY, NOESY,
and HETLOC spectra in CDCl3 for lyngbyabellin L (2) and 7-epi-
lyngbyabellin L (3). 1H NMR, 13C NMR, gHSQC, COSY, HMBC,
and TOCSY spectra in [D6]DMSO for lyngbyabellin N (5). 1H
NMR and 13C NMR in CDCl3 for lyngbyabellin N (5). ORTEP
representation of lyngbyabellin K (1) crystal, and crystal data. CD
spectra for lyngbyabellin K, L, N (1, 2, and 5) and 7-epi-lyngbyab-
ellin L (3).
Preparation of the α-Methoxy-α-(trifluoromethyl)phenylacetic Acid
(MTPA) Ester of Lyngbyabellin M: Duplicate samples of com-
pound 4 (0.5 mg) were dried and dissolved in anhydrous pyridine
(1 mL), and a catalytic amount of 4-(dimethylamino)pyridine was
added. Separately and into each vial, 15 μL of (R)-MTPA chloride
and 15 μL of (S)-MTPA chloride were added. The reaction vials
were stored at 40 °C with stirring for 48 h. The acylation products
were purified by using RP HPLC (Phenomenex Jupiter 5 μ C18,
4.6ϫ250 mm, 85% CH3OH/H2O at 1 mL/min). The m/z values of
the two diastereomeric MTPA derivatives of compound 4 were ob-
Acknowledgments
We thank A. C. Jones, A. R. Pereira, and R. C. Coates for assist-
ance with the collection of the lyngbyabellin-producing cyanobacte-
rial samples from the Palmyra Atoll, C. E. Moore for assistance
with crystallographic data analysis of lyngbyabellin K, as well as
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
9